The Drugs Controller General of India (DCGI) approves Phase II and Phase III clinical trials of COVID-19 vaccine COVAXIN in the age group of 2 to 18 years. According to a tweet by ANI, Bharat Biotech will conduct trials on 525 healthy volunteers. 

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)